Ubs Group Ag Pds Biotechnology Corp Put Options Transaction History
Ubs Group Ag
- $528 Billion
- Q1 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding PDSB
# of Institutions
54Shares Held
8.16MCall Options Held
151KPut Options Held
1.2K-
Armistice Capital, LLC New York, NY4.42MShares$6.19 Million0.08% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.51MShares$2.11 Million0.0% of portfolio
-
Black Rock Inc. New York, NY487KShares$681,7530.0% of portfolio
-
Geode Capital Management, LLC Boston, MA438KShares$613,0330.0% of portfolio
-
Blair William & CO Chicago, IL257KShares$360,0800.0% of portfolio
About PDS Biotechnology Corp
- Ticker PDSB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 28,458,700
- Market Cap $39.8M
- Description
- PDS Biotechnology Corporation, a clinical-stage biopharmaceutical company, focuses on developing multifunctional cancer immunotherapies. Its lead product candidate is PDS0101 (HPV16), which is in Phase II clinical trial provides a first line treatment for the recurrent/metastatic head and neck cancer, human papillomavirus associated malignancies...